Daily aspirin use associated with reduced risk for fibrosis progression in patients with nonalcoholic fatty liver disease

Published 2019 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Daily aspirin use associated with reduced risk for fibrosis progression in patients with nonalcoholic fatty liver disease
Authors
Keywords
prevention, chronic liver disease, anti-inflammatory, anti-fibrotic
Journal
Clinical Gastroenterology and Hepatology
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2019-05-09
DOI
10.1016/j.cgh.2019.04.061

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.